Skip to NavigationSkip to content

News

Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations raised by a whistleblower at the company –...
Top ten stories on Pharmafile.com this week!
Pharmacists have warned that they are struggling to obtain many common generic medicines, as the number of medicines on the ‘shortage of supply’...
Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and twenty-five years...
A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s Venclyxto (venetoclax) in...
Scientists at the University of Washington have developed a gene therapy that prevents the process through which axons (nerve fibres) destroy...
Breast cancer patients in England and Wales now have access to another treatment option, as NICE announces its recommendation of Eli Lilly’s...
Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between 2001 and 2015.
As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm Cephea Valve Technologies, acting...
Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the powerful opioid...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches